. Author manuscript; available in PMC: 2015 Feb 1.

Published in final edited form as: Neuropharmacology. 2013 Oct 10;0:10.1016/j.neuropharm.2013.09.026. doi: 10.1016/j.neuropharm.2013.09.026

Table 2.

Neurotransmitter protein (ng/ml) measured by HPLC (mean ± SEM).

		Nucleus Accumbens			DOPAC/DA	HVA/DA	DA	DOPAC	Frontal Cortex
		NE	Epi	5HT	DOPAC/DA	HVA/DA	DA	DOPAC	HVA

female	control	7.41 ± 2.26	.23 ± .08	4.93 ± .61	.11 ± .02	.06 ± .01	1.02 ± .12	.56 ± .08	.25 ± .03
female	stress	7.05 ± 2.16	.31 ± .07	5.39 ± .90	.11 ± .005	.06 ± .005	1.01 ± .24	.38 ± .12	.21 ± .03
male	control	15.03 ± 2.92^**	.39 ± .10	3.27 ± .93	.12 ± .01	.06 ± .005	1.37 ± .34	.45 ± .05	.24 ± .03
male	stress	14.98 ± 2.53^**	.48 ± .08	6.10 ± 1.43	.11 ± .01	.06 ± .005	.97 ± .28	.36 ± .06	.25 ± .08

main effect of sex

p < 0.05,

^**

p < 0.01